Heartburn & arthritis drugs tested as potential COVID-19 fighters
NCT ID NCT05077332
Summary
This trial tested whether a combination of two existing drugs (famotidine and celecoxib) could help hospitalized COVID-19 patients recover faster and prevent severe illness in newly infected people. The study was small, with only 4 total participants, and aimed to see if this drug combo was safe and effective. One part focused on treating moderate-to-severe hospitalized patients, while another part tested if it could prevent severe symptoms after a recent COVID-19 exposure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
US02-04: Integrated Health Solutions
Miami, Florida, 33126, United States
Conditions
Explore the condition pages connected to this study.